Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
House User Fee Mark-Up: Few Tweaks, But Concerns About ALS And Accelerated Approval
May 19 2022
•
By
Derrick Gingery
Rep. Anna Eshoo discussed the FDA user fee reauthorization and other bills during a House Energy and Commerce Committee mark-up. • Source: screenshot
More from User Fees
More from Pathways & Standards